AI’s Transformative Impact on FDA Oversight in Life Sciences
In the twelfth episode of “When Your Life Sciences Are on the Line,” Kate Driscoll and Nate Mendell discuss the evolving role of artificial intelligence within the FDA with Brigid Bondoc. They explore how AI tools are being integrated to enhance inspection efficiency and address regulatory challenges related to AI-driven clinical decision support software.